AKT1 and cancer: Therapeutic strategies harnessing ROS include ROS inducers, targeting antioxidant systems to sensitize cancer cells to ROS-induced damage and inhibiting survival pathways, such as NF-κB and PI3K/Akt, in synergy with ROS.